Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Squamous Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04293679
What this trial is testing

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

Who this might be right for
Bowen's DiseaseCutaneous Squamous Cell Carcinoma in Situ
Sirnaomics 25
Not applicableEnded earlyNCT01143311
What this trial is testing

Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cancer of the Skin
Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)Looking for participantsNCT06567314
What this trial is testing

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294
What this trial is testing

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Who this might be right for
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more
Oslo University Hospital 20
Not applicableActive Not RecruitingNCT05323253
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma

Who this might be right for
Recurrent Squamous Cell Carcinoma
Alpha Tau Medical LTD. 86
Testing effectiveness (Phase 2)WithdrawnNCT06084845
What this trial is testing

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+12 more
ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Active Not RecruitingNCT02988960
What this trial is testing

ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 163
Testing effectiveness (Phase 2)Study completedNCT03284424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 159
Testing effectiveness (Phase 2)Study completedNCT02964559
What this trial is testing

Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

Who this might be right for
Recurrent Skin CarcinomaSkin Squamous Cell Carcinoma
Emory University 11
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05075980
What this trial is testing

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Who this might be right for
Head and Neck CarcinomaHead and Neck Carcinoma of Unknown PrimaryHypopharyngeal Carcinoma+9 more
Mayo Clinic 174
Early research (Phase 1)Ended earlyNCT04502888
What this trial is testing

Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin

Who this might be right for
Cutaneous Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Shattuck Labs, Inc. 5
Testing effectiveness (Phase 2)Looking for participantsNCT05377905
What this trial is testing

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancers - Squamous Cell Carcinoma
Falo, Louis, MD 48
Not applicableActive Not RecruitingNCT06608511
What this trial is testing

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Who this might be right for
Skin CancerMelanoma (Skin Cancer)Basal Cell Carcinoma of Skin+3 more
University of Wisconsin, Madison 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04808999
What this trial is testing

Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)

Who this might be right for
Squamous Cell Carcinoma
Diwakar Davar 30
Testing effectiveness (Phase 2)Study completedNCT04592484
What this trial is testing

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Codiak BioSciences 27
Not applicableActive Not RecruitingNCT06046625
What this trial is testing

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma+8 more
Maastricht University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT03057613
What this trial is testing

The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07715734
What this trial is testing

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Kidney Transplant RecipientCutaneous Squamous Cell Carcinoma (CSCC)Advanced Cutaneous Squamous Cell Carcinoma+1 more
Washington University School of Medicine 22
Next Page